XWe have detected your location as outside the U.S/Canada, if you think this is wrong, you can choose your location.

Palgrave Macmillan

Impact of TRIPS in India

An Access to Medicines Perspective

ISBN 9780230290747
Publication Date November 2010
Formats Ebook (PDF) Ebook (EPUB) Hardcover 
Publisher Palgrave Macmillan

Over the last three decades, drug prices in India have declined from one of the highest to one of the lowest in the world. Yet, under the current healthcare model, only around 35 per cent of people in India have access to medicines. In the lead up to 2005, when TRIPS compliant regime was introduced in India, there were apprehensions about the drug prices rising under the new regime, which would further restrict access to medicine.

This book examines the impact of TRIPS on drug prices and exports of drugs and pharmaceuticals in India. It goes on to develop a new healthcare model, which if implemented, would extend access to medicines to India's entire population. Sensitivity tests show that the proposed model is affordable, equitable and implementable, and can be replicated in other developing countries.

This book is indispensable reading for all interested in development economics, intellectual property rights in developing countries, pharmaceutical markets and health systems.

PRABODH MALHOTRA was born and brought up in India but has been living in Australia since 1980. Thus, he understands both systems. He has taught at a number of universities in Australia. Prabodh has PhD in Economics and Masters in International Business and has published conference papers, journal articles and government reports in these areas. This book is based on his extensive research and fieldwork in India.

Foreword
Acknowledgments
Introduction
PART I: INFLUENCE OF GLOBAL FORCES ON ACCESS TO MEDICINES
The World Trade Organization and the TRIPS Agreement
The Global Pharmaceutical Industry and Developing New Drugs
PART II: ACCESS TO MEDICINES IN INDIA
Development of India's Pharmaceutical Industry
TRIPS and the Indian Patents Regime
Price Controls and Drug Affordability in India: Policy Options
Health Insurance in India
Broadening the Access to Medicines and Healthcare in India
PART III: GLOBAL PERSPECTIVE
Is TRIPS Appropriate for Developing Countries?
Which Way Ahead?
Final Conclusions
References

Downloads

Reviews

Add a review

Related titles